The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited's Low THC Delta 9 Cannabis cultivars from the unique Australian Cannabis seed bank owned by Medical Cannabis Limited.
The Board at Queensland Bauxite (ASX:QBL) is excited with the recent success and progress of its investment in Medical Cannabis Ltd, particularly as the medicinal focused arm of that Company, Vitacann, has signed a Letter of Intent for a joint venture subject to full documentation with an Israeli recommended group of North American chemists.
Bauxite producer, Australian Bauxite Limited (ASX:ABX) is reporting progress on the ALCORE project in accordance with the schedule announced to the ASX on 13th November 2017.
The Board of Queensland Bauxite (ASX:QBL) is pleased to provide an update on the South Johnstone Bauxite Project.
This week provided further major milestones in Queensland Bauxite's (ASX:QBL) investment in Medical Cannabis Ltd. MCL has made major progress in its Vitahemp brand's "farm-gate to retail" fully vertically integrated journey. Mass production and mass farming is now underway and Australia's largest current hemp seed import for sowing has now cleared quarantine for MCL.
The Board of Queensland Bauxite (ASX:QBL), is anticipating that the successful launch of these premium all-Australian products, will generate significant cashflow for the Company in 2018, and enable dividends for shareholders.
The Board of Queensland Bauxite (ASX:QBL) considers that a monumental milestone has been reached by Medical Cannabis Limited, QBL's Hemp Seed Food production and medicinal Cannabis investment company.
